Dr. Eric Lowe, MD
Claim this profileChildren's Hospital of The King's Daughters
Expert in Tumors
Expert in Brain Tumor
69 reported clinical trials
135 drugs studied
About Eric Lowe, MD
Education:
- Obtained MD from Eastern Virginia Medical School in 2007.
- Completed Residency in Pediatrics at the Children's Hospital of The King's Daughters in 2010.
- Finished Fellowship in Pediatric Cardiology at the Children's Hospital of The King's Daughters in 2013.
Experience:
- Practicing pediatric cardiologist at the Children's Hospital of The King's Daughters.
Area of expertise
1Tumors
Global LeaderStage I
Stage IV
Stage II
2Brain Tumor
Global LeaderStage I
Stage II
Stage IV
Affiliated Hospitals
Clinical Trials Eric Lowe, MD is currently running
Genetic Testing-Directed Therapy
for Pediatric Cancer
This Pediatric MATCH screening and multi-sub-study phase II trial studies how well treatment that is directed by genetic testing works in pediatric patients with solid tumors, non-Hodgkin lymphomas, or histiocytic disorders that have progressed following at least one line of standard systemic therapy and/or for which no standard treatment exists that has been shown to prolong survival. Genetic tests look at the unique genetic material (genes) of patients' tumor cells. Patients with genetic changes or abnormalities (mutations) may benefit more from treatment which targets their tumor's particular genetic mutation, and may help doctors plan better treatment for patients with solid tumors or non-Hodgkin lymphomas.
Recruiting1 award Phase 214 criteria
Selumetinib vs. Chemotherapy
for Brain Cancer
This trial is comparing a new drug, selumetinib, with standard chemotherapy to treat patients with a specific type of brain tumor. The patients do not have a certain genetic mutation and are not affected by a genetic disorder. Selumetinib works by blocking enzymes needed for tumor growth, while the standard drugs kill or stop tumor cells from dividing.
Recruiting2 awards Phase 3
More about Eric Lowe, MD
Clinical Trial Related7 years of experience running clinical trials · Led 69 trials as a Principal Investigator · 32 Active Clinical TrialsTreatments Eric Lowe, MD has experience with
- Cyclophosphamide
- Radiation Therapy
- Etoposide
- Doxorubicin Hydrochloride
- Nivolumab
- Vincristine Sulfate
Breakdown of trials Eric Lowe, MD has run
Tumors
Brain Tumor
Lymphoma
Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Eric Lowe, MD specialize in?
Eric Lowe, MD focuses on Tumors and Brain Tumor. In particular, much of their work with Tumors has involved Stage I patients, or patients who are Stage IV.
Is Eric Lowe, MD currently recruiting for clinical trials?
Yes, Eric Lowe, MD is currently recruiting for 26 clinical trials in Norfolk Virginia. If you're interested in participating, you should apply.
Are there any treatments that Eric Lowe, MD has studied deeply?
Yes, Eric Lowe, MD has studied treatments such as Cyclophosphamide, Radiation Therapy, Etoposide.
What is the best way to schedule an appointment with Eric Lowe, MD?
Apply for one of the trials that Eric Lowe, MD is conducting.
What is the office address of Eric Lowe, MD?
The office of Eric Lowe, MD is located at: Children's Hospital of The King's Daughters, Norfolk, Virginia 23507 United States. This is the address for their practice at the Children's Hospital of The King's Daughters.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.